1-3 of 3
Carsten Grüllich
Close
Sort by
Journal Articles

Cooperative Activity of BRAF F595L and Mutant HRAS in Histiocytic Sarcoma Provides New Insights into Oncogenic BRAF Signaling

Maximilian Kordes, Michael Röring, Christoph Heining, Sandra Braun, Barbara Hutter, Daniela Richter, Christina Geörg, Claudia Scholl, Wilfried Roth, Andreas Rosenwald, MD, Eva Geissinger, Christof von Kalle, Dirk Jäger, Benedikt Brors, Wilko Weichert, Carsten Grüllich, Hanno Glimm, Tilman Brummer, PhD, Stefan Fröhling
Journal: Blood
Blood (2015) 126 (23): 1631.
https://doi.org/10.1182/blood.V126.23.1631.1631
Published: 2015
Journal Articles

Constitutive Expression of the Granzyme B Inhibitor PI-9 Protects Leukemic Cells from Granzyme B Induced Apoptosis.

Carsten Grullich, MD, Kristina Fritsch, Jurgen Finke, MD
Journal: Blood
Blood (2005) 106 (11): 3030.
https://doi.org/10.1182/blood.V106.11.3030.3030
Published: 2005
Journal Articles

Comparison of Conventional Versus Lineage-Specific Chimerism Analysis for Detection of Minimal Residual Disease or Relapse in Myeloid Malignancies after Myeloablative Allogeneic Hematopoietic Cell Transplantation with Respect to Clinical Follow-Up.

Robert Zeiser, M.D., Alexandros Spyridonidis, M.D., Ralph Waesch, M.D., Gabriele Ihorst, Ph.D., Carsten Grullich, M.D., Bertz Hartmut, M.D., Finke Jurgen, M.D.
Journal: Blood
Blood (2004) 104 (11): 1641.
https://doi.org/10.1182/blood.V104.11.1641.1641
Published: 2004